{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:05:43Z","timestamp":1773533143378,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Educationin Japan","award":["18K08076"],"award-info":[{"award-number":["18K08076"]}]},{"name":"Ministry of Educationin Japan","award":["17H04178"],"award-info":[{"award-number":["17H04178"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jjcc.2019.08.020","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T01:34:41Z","timestamp":1576805681000},"page":"454-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design"],"prefix":"10.1016","volume":"75","author":[{"given":"Shigeki","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Wakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hisamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozaburo","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyuki","family":"Hiromoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhji","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuma","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masateru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Obayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Michishige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2019.08.020_bib0005","series-title":"Guidelines for diagnosis and treatment of acute and chronic heart failure (JCS2017\/JHFS2017)","author":"Japanese Circulation Society","year":"2017"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0010","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0015","first-page":"e147","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jjcc.2017.12.010","article-title":"The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation","volume":"72","author":"W\u00e4ndell","year":"2018","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0025","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1253\/circj.CJ-16-0196","article-title":"The current status of cardiovascular medicine in Japan - analysis of a large number of health records from a nationwide claim-based database, JROAD-DPC","volume":"80","author":"Yasuda","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jjcc.2019.03.010","article-title":"Sacubitril\/valsartan in heart failure with reduced ejection fraction patients: real world experience on advanced chronic kidney disease, hypotension, and dose escalation","volume":"74","author":"Chang","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1152\/physrev.1996.76.2.537","article-title":"Malignant hyperthermia: EXCITATION-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects","volume":"76","author":"Mickelson","year":"1996","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0040","doi-asserted-by":"crossref","first-page":"d671","DOI":"10.2741\/ikemoto","article-title":"Regulation of calcium release by interdomain interaction within ryanodine receptors","volume":"7","author":"Ikemoto","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0045","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1074\/jbc.M408375200","article-title":"Dantrolene stabilizes domain interactions within the ryanodine receptor","volume":"280","author":"Kobayashi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0050","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1042\/BJ20041336","article-title":"Probing a putative dantrolene-binding site on the cardiac ryanodine receptor","volume":"387","author":"Paul-Pletzer","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0060","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2009.01.065","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing inter-domain interactions within the ryanodine receptor","volume":"53","author":"Kobayashi","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0065","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.109.209312","article-title":"Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor","volume":"106","author":"Uchinoumi","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0070","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1253\/circj.CJ-10-0680","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2R2474S\/+ knock-in mouse model","volume":"74","author":"Kobayashi","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/emmm.201100194","article-title":"Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Jung","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0080","article-title":"Antiarrhythmic effects of dantrolene in patients with catecholaminergic polymorphic ventricular tachycardia and replication of the responses using iPSC models","volume":"10","author":"Penttinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0085","doi-asserted-by":"crossref","first-page":"H953","DOI":"10.1152\/ajpheart.00936.2011","article-title":"Dantrolene prevents arrhythmogenic Ca2+ release in heart failure","volume":"302","author":"Maxwell","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hrthm.2016.09.014","article-title":"Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes","volume":"14","author":"Hartmann","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0095","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncpcardio0419","article-title":"Mechanisms of disease: ryanodine receptor defects in heart failure and fatal arrhythmia","volume":"3","author":"Yano","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/CIRCRESAHA.111.300290","article-title":"In cardiomyocytes, binding of unzipping peptide activates ryanodine receptor 2 and reciprocally inhibits calmodulin binding","volume":"112","author":"Oda","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0115","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1161\/CIRCULATIONAHA.105.555623","article-title":"Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure","volume":"112","author":"Yano","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/cvr\/cvq108","article-title":"Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca2+ release in heart failure","volume":"87","author":"Ono","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1540-8167.2001.00496.x","article-title":"Arrhythmogenesis in heart failure","volume":"12","author":"Janse","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene\u2014a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jjcc.2019.08.020_bib0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2165\/00003495-198632020-00003","article-title":"Dantrolene. A review of its and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity","volume":"32","author":"Ward","year":"1986","journal-title":"Drugs"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508719302825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508719302825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:02:58Z","timestamp":1760274178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508719302825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0914508719302825"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2019.08.020","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2019.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}